Literature DB >> 11097380

Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism.

I Gut1, V Danielová, J Holubová, P Soucek, H Klucková.   

Abstract

Cytotoxic effects of cyclophosphamide (CPA), paclitaxel (PCT), and docetaxel (DTX) and their modulation by cytochrome P450 (CYP) metabolism were studied by incubating cell lines L929 and P388D1 with or without rat liver microsomes. The microsomes themselves were not cytotoxic. P388D1 cells were more sensitive to CPA, PCT, and DTX than L929 cells. CYP2B1-, CYP3A-, and CYP2E1-induced microsomes effectively oxidized the prodrug CPA to cytotoxic products in 2-h incubation periods. Cytotoxicity of DTX and PCT for P388D1 cells became apparent 24 h after a 2-h incubation period with the drugs, and their effects were enhanced by CYP2E1 microsomes, but markedly decreased by CYP3A-induced microsomes. DTX and PCT without microsomes caused a dose-related cytotoxicity in P388D1 and HeLa cells. P388D1 and HeLa cells did not grow after a 24-h exposure to 1-10 microM DTX, but about 0.1% of cells survived exposure to 1-10 microM PCT. After 4 weeks of multiplication, the surviving P388D1 cells displayed lower sensitivity to DTX and PCT, but cytotoxicity in HeLa cells was unchanged and their growth ability decreased. In P388D1 cells, PCT with DTX (0.1, 0.5. 1, 2.5, or 5 microM) showed only additive cytotoxicity, although they reportedly act in different phases of the cell cycle. In P388D1 cells treated with DTX or PCT, normal mononuclear cells disappeared and the cell diameter increased up to threefold. Mulberry-like nuclei developed, giving rise to multiple nuclei, which were hyper- or hypochromatic. Chromatin condensation in some multiple nuclei and cell shrinkage of some cells fit the definition of apoptosis, but enlargement of the surviving cells and numerous hypochromatic nuclei do not. In conclusion, L929 and P388D1 cells incubated with microsomes enabled the role of various CYP enzymes in the effect of anticancer drugs to be assessed. The delayed cytotoxicity of DTX and PCT compared to that of CPA was related to their different mode of action. Fluorescent microscopy revealed quantitatively different effects of PCT and DTX on the nuclei, indicating that their mode of action may not be completely identical.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097380     DOI: 10.1007/s002040000141

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  12 in total

1.  Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes.

Authors:  Berta Otová; Iwao Ojima; Radka Václavíková; Jiří Hrdý; Marie Ehrlichová; Pavel Souček; Jana Vobořilová; Vlasta Němcová; Ilaria Zanardi; Stanislav Horský; Jan Kovář; Ivan Gut
Journal:  Invest New Drugs       Date:  2011-03-30       Impact factor: 3.850

2.  Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses.

Authors:  Moo-Yeal Lee; Chan Beum Park; Jonathan S Dordick; Douglas S Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

3.  Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.

Authors:  Marie Ehrlichova; Radka Vaclavikova; Iwao Ojima; Antonella Pepe; Larisa V Kuznetsova; Jin Chen; Jaroslav Truksa; Jan Kovar; Ivan Gut
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-30       Impact factor: 3.000

4.  Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa.

Authors:  Yunjung Kim; Sara E Trace; James J Crowley; Kimberly A Brownley; Robert M Hamer; David S Pisetsky; Patrick F Sullivan; Cynthia M Bulik
Journal:  Psychiatry Res       Date:  2013-06-15       Impact factor: 3.222

5.  Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.

Authors:  Radka Václavíková; Stanislav Horský; Petr Simek; Ivan Gut
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-14       Impact factor: 3.000

6.  Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.

Authors:  Xuezhong He; Junyu Ma; Angel E Mercado; Weijie Xu; Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-01-15       Impact factor: 4.200

Review 7.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

8.  Transport, metabolism, cytotoxicity and effects of novel taxanes on the cell cycle in MDA-MB-435 and NCI/ADR-RES cells.

Authors:  Marie Ehrlichová; Iwao Ojima; Jin Chen; Radka Václavíková; Vlasta Němcová-Fürstová; Jana Vobořilová; Petr Simek; Stanislav Horský; Pavel Souček; Jan Kovář; Marek Brabec; Ivan Gut
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-02       Impact factor: 3.000

9.  Effects of Perivitelline Fluid Obtained from Horseshoe Crab on The Proliferation and Genotoxicity of Dental Pulp Stem Cells.

Authors:  Marahaini Musa; Khadijah Mohd Ali; Thirumulu Ponnuraj Kannan; Ahmad Azlina; Nor Shamsuria Omar; Anil Chatterji; Khairani Idah Mokhtar
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

10.  Cytochrome P450 CYP1B1 activity in renal cell carcinoma.

Authors:  M C E McFadyen; W T Melvin; G I Murray
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.